PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Oct-2022 CurvaFix Announces Participation in Orthopaedic Trauma Association Industry Sessions Businesswire
06-Oct-2022 Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor Businesswire
06-Oct-2022 Global Non Invasive Prenatal Testing Market Report (2022 to 2030) - Asia-Pacific is Expected to Exhibit the Highest CAGR Over the Forecast Period - ResearchAndMarkets.com Businesswire
06-Oct-2022 Devonian Health Group Announces Peer-Reviewed Publication of Thykamine™ Positive Phase 2 Clinical Trial Results in Journal of Drugs in Dermatology Businesswire
06-Oct-2022 Global Pre Filled Syringes Market Report to 2028 - Increasing Trend of Home Based Healthcare Among People is Driving Growth - ResearchAndMarkets.com Businesswire
06-Oct-2022 Teva Announces Largest-Ever Trial to Collect Information from Patients and Physicians About TD, its Impact and Progression Over Time, and Evaluate Treatment-Related Outcomes Businesswire
06-Oct-2022 LifeMine Therapeutics Expands Management Team with Appointments of Martin Stahl, Ph.D., as Chief Scientific Officer and Louis Plamondon, Ph.D., as Executive Vice President and Head of CMC Businesswire
06-Oct-2022 The AmerisourceBergen Foundation Commits $100,000 to Support Hurricane Ian Relief Efforts Businesswire
06-Oct-2022 Global Large Volume Parenteral (LVP) Market Report 2022: A Market Valued at $12.9 Billion by 2027 - Malnutrition, Growing Natality Rate, and Increasing Premature Births Worldwide Catalyzing Demand - ResearchAndMarkets.com Businesswire
06-Oct-2022 Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso Businesswire
06-Oct-2022 Peptilogics Announces First Patient Dosed in Phase 1b Study of PLG0206 for Periprosthetic Joint Infection Businesswire
06-Oct-2022 Bayer Names William Dodero New U.S. General Counsel Beginning January 2023 Businesswire
06-Oct-2022 Amneal to Report Third Quarter 2022 Results on November 4, 2022 Businesswire
06-Oct-2022 Seagen to Host Conference Call and Webcast Discussion of Third Quarter 2022 Financial Results on October 27, 2022 Businesswire
06-Oct-2022 ICON selected by BARDA to conduct anthrax vaccine clinical trial Businesswire
06-Oct-2022 Santen annonce l’approbation de CationormMD Plus pour soulager les symptômes de la sécheresse et l’allergie oculaires Businesswire
06-Oct-2022 Santen Announces Health Canada Approval for Cationorm® Plus to Relieve the Symptoms of Dry Eye and Ocular Allergy Businesswire
06-Oct-2022 MAIA Biotechnology to Participate in ThinkEquity Conference Businesswire
06-Oct-2022 Imvax to Present New Data on Tumor-Derived Immunotherapy Platform at 2022 SITC Meeting Businesswire
06-Oct-2022 Horizon Therapeutics plc to Release Third-Quarter 2022 Financial Results and Host Webcast on Nov. 2, 2022 Businesswire